Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.
FR 17027, a new orally absorbed cephalosporin ester, inhibited group A and B streptococci and Streptococcus pneumoniae at less than or equal to 0.1 micrograms/ml, which is similar to the inhibition concentration of amoxicillin and cefaclor, and was more active than cephalexin. It was less active (MI...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1984
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284114/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6333207/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.2.174 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|